Furthermore, LINC02532 promotes the proliferation of HBV-related HCC by targeting miR-455-3p, which suppresses CHEK2, a key DNA damage checkpoint kinase (74). This evidence concerns the gene CHEK2 and hepatocellular carcinoma.